Polymorphic debrisoquin hydroxylation in 757 Swedish subjects
- 1 October 1988
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 44 (4) , 431-435
- https://doi.org/10.1038/clpt.1988.176
Abstract
The metabolic ratios (MRs) between debrisoquin and 4-hydroxydebrisoquin in urine after a single oral dose of 10 mg debrisoqin were bimodally distributed in 757 healthy, white Swedish volunteers. Forty-one subjects (5.4%) had an MR > 12.6 and were classified as slow debrisoquin hydroxylators. The MR was reproducible in urine stored at +8.degree. C for 1 week and at -20.degree. C over a period of 5 years. Collection intervals of 6 or 12 hours gave the same MR. Intraindividual repeatability of the debrisoquin phenotyping test was established in 37 subjects examined twice at least 2 weeks apart. The calculated frequency of the single allele that is believed to control deficient debrisoquin hydroxylation is similar among white Swedish people, as among other white groups examined so far; however, it is significantly different from the frequency in certain Oriental groups. Detailed comparisons of the prevalence of slow debrisoquin hydroxylation in different ethnic groups are not possible due to shortcomings in current epidemiologic techniques used (small materials, the location of he antimode distinguishing rapid and slow hydroxylators unknown, and family studies missing).This publication has 22 references indexed in Scilit:
- Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphismClinical Pharmacology & Therapeutics, 1984
- Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansClinical Pharmacology & Therapeutics, 1984
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsCanadian Journal of Physiology and Pharmacology, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- A study of the debrisoquine hydroxylation polymorphism in a Nigerian populationXenobiotica, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977